Landaas & Company’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-93
Closed -$5K 100
2018
Q2
$5K Buy
+93
New +$5.27K ﹤0.01% 295
2018
Q1
Sell
-93
Closed -$6K 94
2017
Q4
$6K Hold
93
0.01% 279
2017
Q3
$6K Buy
+93
New +$6.57K 0.01% 278

Other funds holding CAH

Landaas & Company's CAH Position: Q3 2018 in Review

Landaas & Company sold out of Cardinal Health (CAH) in Q3 2018, closing a stake of 93 shares — an estimated $5K sold.

Landaas & Company first reported a position in CAH in Q3 2017 and held it in 3 quarters. The position peaked at $6K in Q4 2017. 685 funds tracked by Wall St. Rank hold CAH as of Q3 2018.

  • Landaas & Company reported no remaining Cardinal Health position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 93 Cardinal Health shares in Q3 2018, an estimated $5K.
  • Landaas & Company first reported a position in Cardinal Health in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Cardinal Health position peaked at $6K in Q4 2017.
  • 685 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.